NeoGenomics Revenue 2006-2021 | NEO

NeoGenomics annual/quarterly revenue history and growth rate from 2006 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • NeoGenomics revenue for the quarter ending June 30, 2021 was $0.122B, a 39.95% increase year-over-year.
  • NeoGenomics revenue for the twelve months ending June 30, 2021 was $0.489B, a 20.8% increase year-over-year.
  • NeoGenomics annual revenue for 2020 was $0.444B, a 8.71% increase from 2019.
  • NeoGenomics annual revenue for 2019 was $0.409B, a 47.73% increase from 2018.
  • NeoGenomics annual revenue for 2018 was $0.277B, a 15.19% increase from 2017.
NeoGenomics Annual Revenue
(Millions of US $)
2020 $444
2019 $409
2018 $277
2017 $240
2016 $232
2015 $100
2014 $87
2013 $66
2012 $60
2011 $43
2010 $34
2009 $29
2008 $20
2007 $12
2006 $6
2005 $2
NeoGenomics Quarterly Revenue
(Millions of US $)
2021-06-30 $122
2021-03-31 $116
2020-12-31 $126
2020-09-30 $125
2020-06-30 $87
2020-03-31 $106
2019-12-31 $107
2019-09-30 $105
2019-06-30 $102
2019-03-31 $96
2018-12-31 $76
2018-09-30 $69
2018-06-30 $68
2018-03-31 $63
2017-12-31 $61
2017-09-30 $59
2017-06-30 $62
2017-03-31 $57
2016-12-31 $48
2016-09-30 $61
2016-06-30 $63
2016-03-31 $60
2015-12-31 $27
2015-09-30 $25
2015-06-30 $24
2015-03-31 $23
2014-12-31 $25
2014-09-30 $23
2014-06-30 $21
2014-03-31 $18
2013-12-31 $18
2013-09-30 $17
2013-06-30 $16
2013-03-31 $16
2012-12-31 $15
2012-09-30 $14
2012-06-30 $16
2012-03-31 $15
2011-12-31 $13
2011-09-30 $11
2011-06-30 $10
2011-03-31 $9
2010-12-31 $9
2010-09-30 $9
2010-06-30 $8
2010-03-31 $8
2009-12-31 $8
2009-09-30 $7
2009-06-30 $7
2009-03-31 $7
2008-12-31 $6
2008-09-30 $5
2008-06-30 $5
2008-03-31 $4
2007-12-31 $4
2007-09-30 $3
2007-06-30 $2
2007-03-31 $2
2006-12-31 $2
2006-09-30 $2
2006-06-30 $2
2006-03-31 $1
2005-12-31 $1
2005-09-30 $1
2005-06-30 $0
2005-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.334B $0.444B
NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, hospitals and other reference laboratories throughout the United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.683B 8.63
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00